S 822 · 119th Congress
Scientific EXPERT Act of 2025
Scientific External Process for Educated Review of Therapeutics Act of 2025 or the Scientific EXPERT Act of 2025 This bill requires the Food and Drug Administration (FDA) to facilitate and participate in externally led, science-focused drug development meetings to discuss the development of treatments for rare dise…
- Sponsor
- Klobuchar, Amy (D-Minnesota)
- Introduced
- 2025-03-03
- Policy area
- Health
- Latest action
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Digging through Congress... 🔍